U.S. Markets open in 7 hrs 23 mins

New Autism Balm Hailed as “Anxiety Erasure” Resulting in a Calm, Happy Child

Philadelphia, PA – Olfactory Biosciences Corp. (OLFC) the makers of NOXO Autism Balm(TM) are pleased to announce today the continued success of their
innovative Autism balm. Jacqueline de Vries, Director, Crossroads Center of NJ used NOXO Autism Balm (TM) with a 14YO ASD boy that has come a long way and is now attending a school for children with learning disabilities.

His mom reports that NOXO Autism Balm(TM) is like an anxiety eraser. He gets mellow, calm but also happy. They used it at the Makers Fair last weekend when they had to stand in lines for activities. She reported that everyone on line got calmer. Mom also used it on his younger brother who is in the tweeny stage of emotions and behaviors - he also relaxed and was happier afterwards. She says the wonderful effect seemed to last for about 5 hours."NOXO’s solution provides unprecedented hope for children and families affected by Autism. NOXO Autism Balm(TM) stops the frequency of behavioral issues that trouble children with sensitivities by stopping sensory issues including odors and inducing a calming effect. The Autism Balm provides quick relief to the overstimulated child and allows families to enjoy public settings with fewer worries.

NOXO Autism Balm(TM) is similar to a lip balm but is applied just below the nostrils on the upper lip. Allowing the natural formula to be inhaled and take effect. NOXO’s solution is safe, easy to apply and non-invasive. It works on your body’s natural processes and responses. It is the first successful product to address behavioral issues triggered by sensitivities.

You can get more information on NOXO Autism Balm(TM) at www.noxoinfo.com/autism.html

About Olfactory Biosciences Corp http://www.noxoinfo.com/investor Image: http://www.accesswire.com/images/594/aid.jpg

Olfactory Biosciences Corp.’s NOXO division is focused to develop a variety of products targeting Olfactory Receptors for the desired effect. These alternative medicine wellness products may modify behavior or provide relief to common behavior challenges such as anxiety, smoking or weight control, as examples.


"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements by the Company, statements regarding the NOXO product line, optimism related to the business, expanding ales and other statements in this press release are forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995. Such statements are based on current expectations, estimates and projections about the Company's business. Words such as expects, anticipates, intends, plans, believes, sees, estimates and variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve certain risks and uncertainties that are difficult to predict. Actual results could vary materially from the description contained herein due to many factors including continued market acceptance of the Company's products or the need to raise additional capital. In addition, actual
results could vary materially based on changes or slower growth in the indoor garden market; the potential inability to realize expected benefits and synergies; domestic and international business and economic conditions; changes in customer demand or ordering patterns; changes in the competitive environment including pricing pressures or technological changes; technological advances; shortages of manufacturing capacity; future production variables impacting excess inventory and other risk factors listed from time to time in the Company's Securities and Exchange Commission (SEC) filings under "risk factors" and elsewhere. The forward-looking statements contained in this press release speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this press release.

Richard Stevenson,

Olfactory Biosciences Corp.

333 E. Lancaster Ave. Suite 317

Wynnewood, PA 19096, USA

Phone: 484-278-1626
Source: Olfactory Biosciences Corp.